Carlos Slim, joined by five other billionaires, is giving $100 million to the Bill Gates effort to eradicate polio, reports CNBC's Robert Frank.
Novartis was sued on Tuesday by the United States, which accused the Swiss drug maker of using kickbacks to induce pharmacies to steer thousands of patients to its drug.
Amgen's stock fell sharply in after-hours trading after it reported sales that fell short of Wall Street's expectations.
Big pharma is abandoning antibiotic research at a time when fears over superbugs are growing at an alarming rate, leaving smaller firms to fill the breach.
It will take a mix of approaches to make health care more affordable, Johnson & Johnson CEO Alex Gorsky told CNBC.
Most robotic surgery takes place without a hitch, but a growing number of complaints and lawsuits allege complications and even deaths from Intuitive Surgical's da Vinci device.
If the critics of robotic surgery are right—that safety is an issue—how is that it was performed on 450,000 people last year? The answer may lie in one word: Marketing.
The number of complications from robot-assisted surgery using Intuitive Surgical's da Vinci robot are underreported, allege critics of the procedure, fanning the controversy around the company's pioneering product.
Intuitive Surgical's da Vinci robot was once hailed as a revolution in the operating room, but as more reports of complications have come to light, the da Vinci debate is heating up.
Health care stocks are getting hit hard today, reports CNBC's Bertha Coombs.
Antibiotic-resistant bacteria—often called "superbugs"—are entering the nation's food system and endangering consumers at an alarming rate, according to an analysis of government data.
Some cancers could be cured within the next couple of years, Celgene CEO Robert Hugin told CNBC.
Bird flu originates in birds, but fears of the pandemic are taking a toll on companies like KFC in China, reports CNBC's Michelle Caruso-Cabrera. There have been 10 deaths in the 38 confirmed bird flu cases there.
China is handling an outbreak of bird flu much better than in the past, Sanofi CEO Chris Viehbacher told CNBC on Thursday.
Sanofi CEO Chris Viehbacher shares his opinion on how China has handled recent bird flu concerns and what impact President Obama's budget might have on pharmaceuticals.
Cancer clinics are turning away thousands of Medicare patients. Dr. Jeff Vacira, North Shore Hematology Oncology chief executive; Eric Schnipper, NRAD Medical Associates; and Howard Dean, (D) former Vermont governor.
In addition to superbugs' deadly human toll, associated health costs run into the billions. Some warn that we may never win our war against them as research tapers off.
Bob and Suzanne Wright, co-founders of Autism Speaks, discuss the organization's efforts to foster research and raise awareness about Autism.
Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.
Enrollment season for Medicare Advantage plans and Obama's health reform plan is six months away. One big question is how many people will show up to be insured, reports CNBC's Bertha Coombs.